SOLUGEN INC

Lobbying for SOLUGEN INC · Industrial Biomanufacturing

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Texas · House · Senate · $120,000.00 expenses · posted Jul 21, 2025

Lobbying activity 2

Defense

Support the use of bio-based chemicals in the Department of Defense, generally. FY 2026 Defense Appropriations. FY 2026 National Defense Authorization Act.

Environment/Superfund

Educate policymakers about Solugen's technology to produce bio-based chemicals, generally. Educate policymakers on the Premanufacture Notice decision for glucaric acid under (P.L. 114-182) the Frank R. Lautenberg Chemical Safety for the 21st Century Act and on the Environmental Protection Agency's chemical review process.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.